38062122|t|Autophagy and neuroprotection in astrocytes exposed to 6-hydroxydopamine is negatively regulated by NQO2: relevance to Parkinson's disease.
38062122|a|Dopaminergic degeneration is a central feature of Parkinson's disease (PD), but glial dysfunction may accelerate or trigger neuronal death. In fact, astrocytes play a key role in the maintenance of the blood-brain barrier and detoxification. 6-hydroxydopamine (6OHDA) is used to induce PD in rodent models due to its specific toxicity to dopaminergic neurons, but its effect on astrocytes has been poorly investigated. Here, we show that 6OHDA dose-dependently impairs autophagy in human U373 cells and primary murine astrocytes in the absence of cell death. LC3II downregulation was observed 6 to 48 h after treatment. Interestingly, 6OHDA enhanced NRH:quinone oxidoreductase 2 (NQO2) expression and activity in U373 cells, even if 6OHDA turned out not to be its substrate. Autophagic flux was restored by inhibition of NQO2 with S29434, which correlated with a partial reduction in oxidative stress in response to 6OHDA in human and murine astrocytes. NQO2 inhibition also increased the neuroprotective capability of U373 cells, since S29434 protected dopaminergic SHSY5Y cells from 6OHDA-induced cell death when cocultured with astrocytes. The toxic effects of 6OHDA on autophagy were attenuated by silencing NQO2 in human cells and primary astrocytes from NQO2-/- mice. Finally, the analysis of Gene Expression Omnibus datasets showed elevated NQO2 gene expression in the blood cells of early-stage PD patients. These data support a toxifying function of NQO2 in dopaminergic degeneration via negative regulation of autophagy and neuroprotection in astrocytes, suggesting a potential pharmacological target in PD.
38062122	55	72	6-hydroxydopamine	Chemical	MESH:D016627
38062122	100	104	NQO2	Gene	4835
38062122	119	138	Parkinson's disease	Disease	MESH:D010300
38062122	140	165	Dopaminergic degeneration	Disease	MESH:D009410
38062122	190	209	Parkinson's disease	Disease	MESH:D010300
38062122	211	213	PD	Disease	MESH:D010300
38062122	220	237	glial dysfunction	Disease	MESH:D004194
38062122	264	278	neuronal death	Disease	MESH:D009410
38062122	382	399	6-hydroxydopamine	Chemical	MESH:D016627
38062122	401	406	6OHDA	Chemical	MESH:D016627
38062122	426	428	PD	Disease	MESH:D010300
38062122	466	474	toxicity	Disease	MESH:D064420
38062122	478	498	dopaminergic neurons	Disease	MESH:D009410
38062122	578	583	6OHDA	Chemical	MESH:D016627
38062122	622	627	human	Species	9606
38062122	628	632	U373	CellLine	CVCL:2818
38062122	651	657	murine	Species	10090
38062122	775	780	6OHDA	Chemical	MESH:D016627
38062122	790	818	NRH:quinone oxidoreductase 2	Gene	4835
38062122	820	824	NQO2	Gene	4835
38062122	853	857	U373	CellLine	CVCL:2818
38062122	873	878	6OHDA	Chemical	MESH:D016627
38062122	961	965	NQO2	Gene	4835
38062122	971	977	S29434	Chemical	MESH:C550454
38062122	1056	1061	6OHDA	Chemical	MESH:D016627
38062122	1065	1070	human	Species	9606
38062122	1075	1081	murine	Species	10090
38062122	1094	1098	NQO2	Gene	4835
38062122	1159	1163	U373	CellLine	CVCL:2818
38062122	1177	1183	S29434	Chemical	MESH:C550454
38062122	1207	1213	SHSY5Y	CellLine	CVCL:0019
38062122	1225	1230	6OHDA	Chemical	MESH:D016627
38062122	1304	1309	6OHDA	Chemical	MESH:D016627
38062122	1352	1356	NQO2	Gene	4835
38062122	1360	1365	human	Species	9606
38062122	1400	1404	NQO2	Gene	18105
38062122	1408	1412	mice	Species	10090
38062122	1488	1492	NQO2	Gene	4835
38062122	1543	1545	PD	Disease	MESH:D010300
38062122	1546	1554	patients	Species	9606
38062122	1599	1603	NQO2	Gene	4835
38062122	1607	1632	dopaminergic degeneration	Disease	MESH:D009410
38062122	1754	1756	PD	Disease	MESH:D010300
38062122	Association	MESH:D010300	4835
38062122	Positive_Correlation	MESH:D016627	4835
38062122	Positive_Correlation	MESH:D016627	MESH:D010300
38062122	Association	MESH:D009410	4835
38062122	Positive_Correlation	MESH:D016627	MESH:D009410
38062122	Negative_Correlation	MESH:C550454	4835
38062122	Negative_Correlation	MESH:C550454	MESH:D016627

